Richard Sorgnard is the executive director for Morhea Technologies which creates electronic/electric signal generation technology and applied techniques for the medical, governmental and consumer electronics industries. Richard Sorgnard proprietary technology is currently used (under Morhea license) by multiple companies in the medical industry.
After serving in the United States Air force, Richard Sorgnard studied at Northwest Missouri State University, graduating with a Bachelor’s and Master’s Degree in Biology. Richard Sorgnard continued his studies by then graduating from Northwestern University with a PHD in Molecular Cell Biology. Richard Sorgnard is actively involved in the design, development, engineering and production of complex electronic equipment, electric signal generation (EST) devices (including FHSS signaling), as well as applied techniques for the medical, governmental and consumer electronics industries.
Richard Sorgnard is also the Director of Technology at the International Institute for Chronic Disease in creating clinical trial technology and protocol development for various chronic disease states.